First human endothelial cell atlas maps how blood vessels age
On Oct. 27, 2026, to uncover how endothelial cells, the inner linings of blood vessels. change over the…
-
-
1st Recipient of iPS Cell Sheet Transplant Set for Discharge
On Oct. 21, 2026, a woman in her 50s who received the first transplant of heart muscle cell…
-
Biotechnology | Cardiology | Disease | Genomics | Neurology | NIH | Oncology
Large-scale study advances detection of DNA mutations across the human genome
On Oct. 15, 2026, researchers in a Mayo Clinic-led study have shown how to detect a broad range…
-
Artificial Intelligence | Biotechnology | Cardiology | Diagnostics | Genomics | Medicine | Neurology | NIH | Oncology | Telemedicine
Georgia Tech Opens Super Computer to researchers nationwide
On Oct. 12, 2026, Georgia Tech announced it is opening a new frontier in scientific computing with Nexus,…
-
FDA Approves First Heart Valve Designed to Grow with Children
On Oct. 1, 2026, the U.S. Food and Drug Administration (FDA) approved Edwards Lifesciences’s Autus Size-Adjustable Valve, a…
-
FDA Approves Bayer’s KERENDIA® (finerenone) as First New Treatment in 30 Years for Adults with Chronic Kidney Disease and Type 1 Diabetes
On Sept. 17, 2026, Bayer announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to…
-
$1.1 billion from Nike co-founder will build Oregon’s first women’s hospital
On Sept. 15, 2026, Oregon billionaires Phil and Penny Knight committed $1.1 billion to the Providence St. Vincent…
-
Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms
On Sept. 8, 2026, Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for the…
-
Melbourne researchers create human heart valve tissues from stem cells in world-first discovery
On Aug. 12, 2026, a research team from Murdoch Children’s Research Institute (MCRI) has produced lab grown heart…
-
Merck’s LIPFENDRA® (enlicitide) Approved by the FDA to Reduce Cholesterol
On Jul. 16, 2026, Merck announced the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA® (enlicitide) tablets…
-
Biotechnology | Cardiology | Diagnostics | Implants | Medical Device | Therapeutics | WHO
WHO advances global regulatory cooperation with first interim list of regulatory authorities for medical devices
On Jul. 14, 2026, the World Health Organization (WHO) published its first interim list of regulatory authorities for…
-
Biotechnology | Cardiology | Diagnostics | FDA | Neurology | NIH | Rare Disease | Therapeutics | Women's Health
NIH invests $150 million in human-based research to reduce use of animal models
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
-
Second $75 million gift from Phil and Penny Knight expands possibilities in care
On Feb. 19, 2026, Phil and Penny Knight announced they have given a second transformational gift of $75 million…
-
Cardiology | Diagnostics | Disease | Energy | Environmental | EPA | Genomics | Neurology | Oncology | U.S. Congress | Women's Health
EPA revokes scientific finding that underpinned US fight against climate change
On Feb. 12 2026, the Trump administration revoked a scientific finding that long has been the central basis…
-
Statins do not cause the majority of side effects listed in package leaflets
On Feb. 6, 2026, a study led by researchers at Oxford Population Health reported that statins do not…
-
Experimental pill dramatically reduces ‘bad’ cholesterol
On Feb. 4, 2026, researchers from UT Southwestern Medical Center report that an experimental pill called enlicitide slashed…
-
Vanderbilt Transplant Center sets world record for heart transplants in 2024
On Jan. 13, 2026, The Vanderbilt Transplant Center had a banner year in 2024, setting a world record…
-
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases for $1.2 billion
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
-
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
-
Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 Years
On Dec. 18, 2025, new national and state data was released by the Partnership to Fight Chronic Disease…
-
Penn researchers awarded $25M to conduct trial using smartphones to fight heart disease
On Dec. 16, 2025, The largest-ever study testing the effectiveness of an evidence-based approach to increasing physical activity…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
-
Biotechnology | Cardiology | Disease | Therapeutics | WHO
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
On Dec. 1, 2025, the World Health Organization (WHO) has released its first guideline on the use of…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
-
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
-
Genetic variant increases risk of heart muscle disease common in individuals of African ancestry
On Oct. 31, 2025, investigators from Mass General Brigham, the Broad Institute of MIT and Harvard, and VA…
-
Lilly announces $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the U.S.
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
-
Biology | Cardiology | Diagnostics | Disease | Environmental | EPA | Neurology | Non-Profit Research | WHO | Women's Health
Nearly 9 in 10 air pollution deaths are from noncommunicable diseases
On. Oct. 23, 2025, Air pollution continues to exacerbate global health, including noncommunicable diseases and dementia, according to…
-
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
-
FDA approves Novo Nordisk’s oral semaglutide for cardiovascular risk reduction in adults with type 2 diabetes
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
